Search

everythinglearnresearchcommunity

for

Search:↓

Higher androstenedione levels in women with PCOS are linked to more severe symptoms.

The rat model showed early perimenopause with regular cycles and low hormones, and late perimenopause with irregular cycles and higher hormone levels.

Flutamide combined with a low-dose birth control pill effectively reduces excessive hair growth in women with polycystic ovarian disease.

Local hormonal treatment for vulvovaginal atrophy is likely safe for women with estrogen receptor-positive breast cancer on aromatase inhibitors.

High Nesfatin-1 and low Vitamin D may increase blood pressure and heart rate in women with PCOS.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.

Taking oral testosterone with or without dutasteride increases testosterone levels and could be an effective treatment for low testosterone.

New signs like changes in blood markers, physical symptoms, and behavioral shifts may help detect hidden steroid use in athletes.

Interleukin-2 treatment improved hair growth, sexual function, and reduced fungal infection in a patient with thymoma-related symptoms.

The treatment significantly reduced hair growth and male hormone levels in hirsute women.

Some conditions mimic PCOS symptoms and need careful diagnosis to treat potentially serious health issues.

Testosterone is crucial for development, growth, and various body functions in mammals.

Quercetin may help improve symptoms of polycystic ovary syndrome.

The woman's high testosterone levels indicated PCOS, leading to treatment that improved her symptoms.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

Women with PCOS may have a higher risk of respiratory and ear infections due to slower nasal mucociliary clearance.

Chemotherapy caused a woman's permanent hair loss and early menopause.

PCOS is a common hormonal disorder in women linked to several health risks and can be managed through various treatments.

Orlistat helped reduce weight and testosterone in obese women with PCOS but did not significantly affect other androgens or cholesterol levels.

The document concludes that managing PCOS involves lifestyle changes, medication for symptoms, and weight loss for fertility improvement.

The study concluded that a higher waist-hip ratio significantly increases the risk of metabolic syndrome in women with PCOS.

Insulin resistance is linked to larger thyroid volume in patients with polycystic ovary syndrome.

Menstrual abnormalities in PCOS women may not greatly affect their metabolic and hormonal profile.

Male hormones and their interactions are crucial for male sexual development and characteristics.

Obesity is a major risk factor for insulin resistance in Taiwanese women with PCOS, which is also an independent risk factor for metabolic syndrome.

The new rodent model successfully mimics non-lean human PCOS symptoms.

PCOS is often linked with menstrual issues, hormonal imbalances, and a higher risk of heart disease and diabetes.

Obese women with PCOS have lower zinc levels than non-obese ones.

PCOS is diagnosed when at least two of these three features are present: polycystic ovaries, irregular ovulation, and high androgen levels.